UVV Q1 2026 Earnings EPS Miss Signals Challenging Start to Fiscal Year SOWG Q3 2025 Earnings Significant EPS Miss Amid Challenging Quarter CLDI Q4 2025 Earnings Smallerthanexpected loss highlights progress in clinicalstage biotherapeutics FNLC Q1 2026 Earnings Modest Performance Amid Narrowing Margins MRAM Q1 2026 Earnings EPS Beats Estimates by 19 Stock Edges Higher GBDC Q1 2026 Earnings Significant EPS Miss Amid Challenging Market Conditions